TY - JOUR
T1 - Chronic pancreatitis
AU - Thierens, Naomi DE
AU - Verdonk, Robert C.
AU - Löhr, J. Matthias
AU - van Santvoort, Hjalmar C.
AU - Bouwense, Stefan AW
AU - van Hooft, Jeanin E.
N1 - Publisher Copyright:
© 2025 Elsevier Ltd
PY - 2024/12/21
Y1 - 2024/12/21
N2 - Chronic pancreatitis is a progressive fibroinflammatory disease primarily caused by a complex interplay of environmental and genetic risk factors. It might result in pancreatic exocrine and endocrine insufficiency, chronic pain, reduced quality of life, and increased mortality. The diagnosis is based on the presence of typical symptoms and multiple morphological manifestations of the pancreas, including pancreatic duct stones and strictures, parenchymal calcifications, and pseudocysts. Management of chronic pancreatitis consists of prevention and treatment of complications, requiring a multidisciplinary approach focusing on lifestyle modifications, exocrine insufficiency, nutritional status, bone health, endocrine insufficiency, pain management, and psychological care. To optimise clinical outcomes, screening for complications and evaluation of treatment efficacy are indicated in all patients with chronic pancreatitis.
AB - Chronic pancreatitis is a progressive fibroinflammatory disease primarily caused by a complex interplay of environmental and genetic risk factors. It might result in pancreatic exocrine and endocrine insufficiency, chronic pain, reduced quality of life, and increased mortality. The diagnosis is based on the presence of typical symptoms and multiple morphological manifestations of the pancreas, including pancreatic duct stones and strictures, parenchymal calcifications, and pseudocysts. Management of chronic pancreatitis consists of prevention and treatment of complications, requiring a multidisciplinary approach focusing on lifestyle modifications, exocrine insufficiency, nutritional status, bone health, endocrine insufficiency, pain management, and psychological care. To optimise clinical outcomes, screening for complications and evaluation of treatment efficacy are indicated in all patients with chronic pancreatitis.
UR - http://www.scopus.com/inward/record.url?scp=85212348492&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(24)02187-1
DO - 10.1016/S0140-6736(24)02187-1
M3 - Review article
C2 - 39647500
AN - SCOPUS:85212348492
SN - 0140-6736
VL - 404
SP - 2605
EP - 2618
JO - The Lancet
JF - The Lancet
IS - 10471
ER -